Related Experiment Video
Updated: Jul 9, 2026

Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
Trace amine-associated receptor 1 modulates dopaminergic activity.
Lothar Lindemann1, Claas Aiko Meyer, Karine Jeanneau
1Pharmaceuticals Division, Central Nervous System Research, Department PRDNP5 CH, Bldg. 70/331, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland.
Trace amine-associated receptor 1 (TAAR1) regulates dopamine transporter effects. TAAR1 knockout mice show heightened amphetamine sensitivity, revealing TAAR1
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Trace amine-associated receptor 1 (TAAR1) is a recently identified receptor.
- TAAR1 plays a role in mediating the effects of trace amines.
- Dopamine transporter (DAT) interactions with trace amines are complex.
Purpose of the Study:
- To differentiate TAAR1-mediated effects from DAT-mediated effects of trace amines.
- To investigate the physiological role of TAAR1 in dopaminergic neurotransmission.
- To characterize the behavioral and neurochemical consequences of TAAR1 deficiency.
Main Methods:
- Generation and utilization of a Taar1 knockout mouse model.
- Assessment of locomotor activity in response to amphetamine.
- Measurement of extracellular dopamine levels in the striatum via microdialysis.
- Electrophysiological recordings of dopaminergic neurons in the ventral tegmental area.
- Administration of the TAAR1 agonist p-tyramine.
Main Results:
- Taar1 knockout mice exhibited increased locomotor activity and dopamine release upon amphetamine administration compared to wild-type mice.
- Baseline locomotion and striatal dopamine levels were comparable between knockout and wild-type mice.
- Dopaminergic neurons in the ventral tegmental area of knockout mice showed a higher spontaneous firing rate.
- p-tyramine reduced dopaminergic neuron firing in wild-type mice but not in knockout mice, confirming TAAR1's role.
Conclusions:
- TAAR1 acts as a significant regulator of dopaminergic neurotransmission.
- TAAR1 modulates the sensitivity of the dopamine system to psychostimulants like amphetamine.
- The findings highlight TAAR1 as a potential therapeutic target for neurological and psychiatric disorders involving dopamine dysregulation.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Drugs Affecting Neurotransmitter Release or Uptake
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Neurochemical Transmission: Sites of Drug Action
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...

